JPWO2019246508A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019246508A5 JPWO2019246508A5 JP2020571400A JP2020571400A JPWO2019246508A5 JP WO2019246508 A5 JPWO2019246508 A5 JP WO2019246508A5 JP 2020571400 A JP2020571400 A JP 2020571400A JP 2020571400 A JP2020571400 A JP 2020571400A JP WO2019246508 A5 JPWO2019246508 A5 JP WO2019246508A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- subunit
- amino acid
- heterodimer
- charge polarization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023098823A JP7452932B2 (ja) | 2018-06-21 | 2023-06-15 | ヘテロ二量体タンパク質及びその使用 |
| JP2024032407A JP2024057087A (ja) | 2018-06-21 | 2024-03-04 | ヘテロ二量体タンパク質及びその使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862688167P | 2018-06-21 | 2018-06-21 | |
| US62/688,167 | 2018-06-21 | ||
| US201862703248P | 2018-07-25 | 2018-07-25 | |
| US62/703,248 | 2018-07-25 | ||
| PCT/US2019/038451 WO2019246508A1 (en) | 2018-06-21 | 2019-06-21 | Heterodimeric proteins and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023098823A Division JP7452932B2 (ja) | 2018-06-21 | 2023-06-15 | ヘテロ二量体タンパク質及びその使用 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021527700A JP2021527700A (ja) | 2021-10-14 |
| JP2021527700A5 JP2021527700A5 (https=) | 2022-06-28 |
| JPWO2019246508A5 true JPWO2019246508A5 (https=) | 2022-06-28 |
| JP7439372B2 JP7439372B2 (ja) | 2024-02-28 |
Family
ID=68983045
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020571400A Active JP7439372B2 (ja) | 2018-06-21 | 2019-06-21 | ヘテロ二量体タンパク質及びその使用 |
| JP2023098823A Active JP7452932B2 (ja) | 2018-06-21 | 2023-06-15 | ヘテロ二量体タンパク質及びその使用 |
| JP2024032407A Pending JP2024057087A (ja) | 2018-06-21 | 2024-03-04 | ヘテロ二量体タンパク質及びその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023098823A Active JP7452932B2 (ja) | 2018-06-21 | 2023-06-15 | ヘテロ二量体タンパク質及びその使用 |
| JP2024032407A Pending JP2024057087A (ja) | 2018-06-21 | 2024-03-04 | ヘテロ二量体タンパク質及びその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US10995127B2 (https=) |
| EP (1) | EP3810172A4 (https=) |
| JP (3) | JP7439372B2 (https=) |
| KR (1) | KR20210025054A (https=) |
| CN (1) | CN112566650A (https=) |
| AU (1) | AU2019290192A1 (https=) |
| BR (1) | BR112020026112A2 (https=) |
| CA (1) | CA3103975A1 (https=) |
| MX (1) | MX2020014031A (https=) |
| WO (1) | WO2019246508A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210025054A (ko) * | 2018-06-21 | 2021-03-08 | 샤턱 랩스 인코포레이티드 | 이형이량체 단백질 및 이의 용도 |
| AU2020340424A1 (en) * | 2019-08-30 | 2022-03-31 | Shattuck Labs, Inc. | Chimeric proteins in autoimmunity |
| WO2021202354A1 (en) * | 2020-03-30 | 2021-10-07 | Proviva Therapeutics (Hong Kong) Limited | Il-2/il-15 compositions and methods of use thereof |
| US12012441B2 (en) | 2020-10-26 | 2024-06-18 | Neptune Biosciences Llc | Engineered human IL-21 cytokines and methods for using the same |
| WO2022241058A1 (en) | 2021-05-12 | 2022-11-17 | Applied Biomedical Science Institute | Methods of screening and expression of disulfide-bonded binding polypeptides |
| US20240262893A1 (en) | 2021-05-12 | 2024-08-08 | Applied Biomedical Science Institute | Binding polypeptides against sars cov-2 and uses thereof |
| WO2023205738A2 (en) * | 2022-04-20 | 2023-10-26 | Neptune Biosciences Llc | Orthogonal il-21 receptor/cytokine systems |
| CA3256783A1 (en) | 2022-05-16 | 2023-11-23 | Enkefalos Biosciences, Llc | Blood-brain barrier translocation peptides and associated molecules and their methods of use |
| WO2024019984A1 (en) * | 2022-07-18 | 2024-01-25 | Cargo Therapeutics, Inc. | Cytokine receptor switch polypeptides and uses thereof |
| EP4619430A1 (en) | 2022-11-16 | 2025-09-24 | Applied Biomedical Science Institute | Fusion polypeptides and binding peptides and methods for producing and using same |
| WO2024123812A1 (en) | 2022-12-05 | 2024-06-13 | Shattuck Labs, Inc. | Fusion proteins for the treatment of cardiometabolic diseases |
| WO2025133115A1 (en) * | 2023-12-21 | 2025-06-26 | Ose Immunotherapeutics | Lipid-based nanoparticles comprising il-35 |
| WO2025140436A1 (zh) * | 2023-12-27 | 2025-07-03 | 上海药明生物技术有限公司 | 重组il-27蛋白及其制备方法 |
| CN117986386B (zh) * | 2024-02-06 | 2024-11-29 | 康立泰生物医药(青岛)有限公司 | 重组人白细胞介素-35及其制备方法和应用 |
| US20260035414A1 (en) * | 2024-08-01 | 2026-02-05 | Twilight Bioscience, Inc. | Herv-k (hml-2) env analog fusion proteins for antigen specific immunotherapy and methods of use |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE196297T1 (de) * | 1994-05-18 | 2000-09-15 | Synthetic Peptides Inc | Heterodimere trägerzusammensetzung von immunogenen polypeptiden und verfahren zu deren verwendung |
| IT1274350B (it) * | 1994-12-06 | 1997-07-17 | Angeletti P Ist Richerche Bio | Antagonisti di interleuchina-6(il-6) che consistono di forme solubili del ricettore alfa di il-6, mutate nell'interfaccia che si lega a gp 130 |
| ATE295887T1 (de) | 1996-02-20 | 2005-06-15 | Applied Research Systems | Heterodimerebildende hybrid-proteine |
| EP1489100B1 (en) * | 1997-12-08 | 2016-06-15 | Merck Patent GmbH | Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| SK782002A3 (en) | 1999-07-21 | 2003-08-05 | Lexigen Pharm Corp | FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| JP4793971B2 (ja) * | 1999-08-09 | 2011-10-12 | メルク パテント ゲーエムベーハー | 複合サイトカイン−抗体複合体 |
| ES2381650T3 (es) * | 2000-08-08 | 2012-05-30 | Zymogenetics, Inc. | Receptores de citoquinas Zcytor11 solubles |
| ATE498633T1 (de) * | 2004-07-09 | 2011-03-15 | Variety Children S Hospital D B A Miami Children S Hospital | Materialien und verfahren zur stimulierung des immunsystems |
| EP2072527A1 (en) * | 2007-12-21 | 2009-06-24 | Altonabiotec AG | Fusion polypeptides comprising a SHBG dimerization component and uses thereof |
| KR20120108967A (ko) * | 2009-09-16 | 2012-10-05 | 제넨테크, 인크. | 코일드 코일 및/또는 테더 함유 단백질 복합체 및 그의 용도 |
| CN102958942A (zh) | 2009-12-29 | 2013-03-06 | 新兴产品开发西雅图有限公司 | 异二聚体结合蛋白及其应用 |
| EP4012714A1 (en) * | 2010-03-23 | 2022-06-15 | Iogenetics, LLC. | Bioinformatic processes for determination of peptide binding |
| UY35148A (es) * | 2012-11-21 | 2014-05-30 | Amgen Inc | Immunoglobulinas heterodiméricas |
| CA2902739C (en) * | 2013-03-15 | 2022-11-22 | Xencor, Inc. | Heterodimeric proteins |
| US10017545B2 (en) * | 2013-06-03 | 2018-07-10 | University Of Maryland, College Park | Compositions and vaccines comprising vesicles and methods of using the same |
| WO2017019623A2 (en) * | 2015-07-26 | 2017-02-02 | Molecular Templates, Inc. | Cell-targeting molecules comprising shiga toxin a subunit effectors and cd8+ t-cell epitopes |
| HK1243629A1 (zh) | 2014-09-17 | 2018-07-20 | 基因泰克公司 | 包含抗her2抗体和吡咯并苯并二氮杂䓬的免疫缀合物 |
| CN104403004B (zh) * | 2014-11-24 | 2017-10-13 | 苏州丁孚靶点生物技术有限公司 | 抗体‑干扰素异二聚体的制备和用途 |
| CA2978186A1 (en) * | 2015-03-05 | 2016-09-09 | Fred Hutchinson Cancer Research Center | Immunomodulatory fusion proteins and uses thereof |
| RU2766200C1 (ru) | 2015-10-01 | 2022-02-09 | Хит Байолоджикс, Инк. | Композиции и способы для соединения внеклеточных доменов типа i и типа ii в качестве гетерологичных химерных белков |
| US10954301B2 (en) | 2015-12-14 | 2021-03-23 | Macrogenics, Inc. | Bispecific molecules having immunoreactivity with PD-1 and CTLA-4, and methods of use thereof |
| CN118307682A (zh) * | 2016-09-27 | 2024-07-09 | 埃皮辛特瑞柯斯公司 | 免疫调节性融合蛋白 |
| US12447213B2 (en) * | 2016-10-07 | 2025-10-21 | The Broad Institute, Inc. | Modulation of novel immune checkpoint targets |
| MX2019009812A (es) * | 2017-02-27 | 2019-10-14 | Shattuck Labs Inc | Proteinas quimericas basadas en tigit y light. |
| KR20210025054A (ko) * | 2018-06-21 | 2021-03-08 | 샤턱 랩스 인코포레이티드 | 이형이량체 단백질 및 이의 용도 |
| US11098093B2 (en) * | 2019-01-07 | 2021-08-24 | Shattuck Labs, Inc. | Heterodimeric proteins for modulating gamma delta T cells |
| AU2020340424A1 (en) * | 2019-08-30 | 2022-03-31 | Shattuck Labs, Inc. | Chimeric proteins in autoimmunity |
-
2019
- 2019-06-21 KR KR1020217001659A patent/KR20210025054A/ko not_active Ceased
- 2019-06-21 EP EP19823119.3A patent/EP3810172A4/en not_active Withdrawn
- 2019-06-21 CA CA3103975A patent/CA3103975A1/en active Pending
- 2019-06-21 BR BR112020026112-2A patent/BR112020026112A2/pt unknown
- 2019-06-21 CN CN201980053803.4A patent/CN112566650A/zh active Pending
- 2019-06-21 AU AU2019290192A patent/AU2019290192A1/en not_active Abandoned
- 2019-06-21 JP JP2020571400A patent/JP7439372B2/ja active Active
- 2019-06-21 MX MX2020014031A patent/MX2020014031A/es unknown
- 2019-06-21 WO PCT/US2019/038451 patent/WO2019246508A1/en not_active Ceased
- 2019-09-16 US US16/571,853 patent/US10995127B2/en active Active
-
2021
- 2021-03-24 US US17/211,180 patent/US11780897B2/en active Active
-
2023
- 2023-01-17 US US18/155,218 patent/US20230220030A1/en not_active Abandoned
- 2023-06-15 JP JP2023098823A patent/JP7452932B2/ja active Active
-
2024
- 2024-03-04 JP JP2024032407A patent/JP2024057087A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021527700A5 (https=) | ||
| JP7350041B2 (ja) | アゴニストおよびアンタゴニストとしての循環置換により修飾されるリガンド | |
| JPWO2019246508A5 (https=) | ||
| KR102322510B1 (ko) | 수용체 결합친화성이 현격히 감소된 사이토카인을 수반하는 푸소카인 | |
| Fischer et al. | A bioactive designer cytokine for human hematopoietic progenitor cell expansion | |
| US20070087411A1 (en) | Monomeric self-associating fusion polypeptides and therapeutic uses thereof | |
| CN112105634A (zh) | 新型白介素2及其用途 | |
| JPH08507676A (ja) | 可溶性オリゴマー蛋白質の調製法 | |
| EP4019536A1 (en) | Immunocytokine, preparation for same, and uses thereof | |
| KR20220025698A (ko) | 다기능 융합 단백질 및 이의 용도 | |
| CN117500824A (zh) | 包含IL-10或TGF-β激动剂多肽的嵌合分子 | |
| JP2023543440A (ja) | 二重特異性組換えタンパク質及びその使用 | |
| CN110669139A (zh) | 二聚体免疫粘附素、药物组合物和用途 | |
| KR20210006302A (ko) | 신규 il-10 변이체 단백질 및 그의 용도 | |
| JP2014124186A (ja) | 多価抗体フラグメントおよびその三量体化複合体 | |
| CN117561280A (zh) | 携带TGF-β的抗原呈递多肽复合物及其使用方法 | |
| CA3180251A1 (en) | Cytokine conjugates | |
| US20250223330A1 (en) | Designed cytokine compositions and methods of use | |
| JP7796754B2 (ja) | インターロイキン－２ムテイン及びその使用 | |
| KR20260040610A (ko) | 설계된 인터루킨-2 사이토카인 조성물 및 사용 방법 | |
| US20250115657A1 (en) | Bispecific FC Fusion Proteins with sPD-1 and IL-15 | |
| CN116375880A (zh) | 融合蛋白及其制备方法和应用 | |
| JPWO2022258662A5 (https=) | ||
| US11555060B2 (en) | QTY FC fusion water soluble receptor proteins | |
| WO2026036390A1 (zh) | 白介素12突变体及其用途 |